Monoclonal Antibody Treatments:
High Risk Patients & Those with Underlying Conditions

 

Under the revised FDA Expanded Use Authorization [EUA], someone who is at “HIGH RISK for progressing to severe COVID-19 and / or hospitalization” may include, but is not limited to, someone who has one of the conditions listed below: (**For full list of underlying conditions, refer to CDC Guide for People with Certain Medical Conditions)

*These lists are intended as a guide only.
Consult your physician or healthcare facility for details and to see if this treatment is right for you.

 
 

Chronic Lung Disease - including, though not limited to:

  • Active Tuberculosis (TB)  

  • Asbestosis  

  • Asthma/Reactive airway disease  

  • Bronchiectasis  

  • Bronchiolitis obliterans  

  • Chronic bronchitis  

  • Chronic respiratory failure  

  • Cystic Fibrosis (CF)  

  • Emphysema/Chronic obstructive pulmonary disease (COPD)  

  • Interstitial lung disease (ILD)  

  • Obstructive sleep apnea (OSA)  

  • Oxygen (O2) dependent  

  • Pulmonary fibrosis  

  • Restrictive lung disease  

  • Sarcoidosis 

Cardiovascular Disease - including, though not limited to:

  • Aortic aneurysm  

  • Valvular heart disease or valve replacement  

  • Atherosclerotic cardiovascular disease (ASCVD)  

  • Atrial fibrillation (AFib)  

  • Atrioventricular (AV) blocks  

  • Automated implantable devices (AID/AICD) / Pacemaker  

  • Bundle branch block (BBB, LBBB, RBBB) 

  • Cardiomyopathy  

  • Carotid stenosis  

  • Stroke  

  • Congenital heart disease  

  • Coronary artery bypass grafting (CABG)  

  • Coronary artery disease (CAD)  

  • Deep vein thrombosis (DVT)  

  • Congestive heart failure (CHF)

  • Hypertension  

  • Myocardial infarction (MI)  

  • Peripheral artery disease (PAD)  

  • Peripheral vascular disease (PVD)  

  • Pulmonary embolism (PE)  

  • Pulmonary hypertension (PHTN)  

  • Transient ischemic attack (TIA)  

  • History of Ventricular fibrillation (VF, VFib)  

  • History of Ventricular tachycardia (VT, VTach)  

Chronic Kidney Disease - including though not limited to:

  • Chronic kidney disease (CKD)/ Chronic renal insufficiency (CRI) 

  • Dialysis (HD)  

  • End stage renal disease (ESRD)  

  • Glomerulonephritis (GN)  

  • Nephrotic syndrome  

  • Polycystic kidney disease (PCKD)  

Immunosuppressive Disease - including, though not limited to:

  • AIDS or CD4 count < 200  

  • Complement deficiency  

  • Grafts-Vs-Host disease (GVHD)  

  • HIV infection  

  • Immunoglobulin deficiency/ Immunodeficiency  

  • Immunosuppressive therapy (within the last 12 months)  

  • Leukemia  

  • Lymphoma (Hodgkins/ Non-Hodgkins (NHL))  

  • Metastatic cancer  

  • Multiple Myeloma  

  • Solid organ malignancy  

  • Steroid therapy (within past 2 weeks)  

  • Bone marrow transplant (BMT) or peripheral stem cell transplant (PSCT)  

  • Solid organ transplant  

Neuro-Developmental Diseases - including though not limited to:

  • Cerebral palsy

  • Down Syndrome/ Trisomy 21

  • Edward's syndrome/ Trisomy 18

  • Epilepsy/ Seizure/ Seizure disorder

  • Mitochondrial disorder

  • Muscular dystrophy

  • Neural tube defects/ Spina bifida